SWS Medical Unveils Next-Generation Kidney Innovation at ERA 2026 Congress

SWS Medical Showcases Kidney Innovations at ERA 2026

In an exciting development for the field of nephrology, SWS Medical has announced its debut at the upcoming ERA 2026 Congress, scheduled from June 3 to 6 in Glasgow. This esteemed event will bring together nephrologists, industry leaders, and partners, providing a platform for SWS Medical to present its latest advancements in blood purification technology.

Based in Chongqing, China, SWS Medical is recognized for its commitment to enhancing the global dialysis and blood purification landscape, particularly within intensive care settings. At ERA 2026, the company will unveil its state-of-the-art dialysis and Continuous Renal Replacement Therapy (CRRT) platforms designed to optimize smart automation, connected care, workflow efficiency, and integrated therapy management.

Among the technologies to be highlighted are the SWS-4000 and SWS-6000 series, which are leading platforms in China’s dialysis market, collectively accounting for about 20% of the country’s dialysis machine market in 2025. Notably, the SWS-6000 stands out as China’s only dialysis machine equipped with certified monitoring for key treatment parameters. Meanwhile, the SWS-4000 features an in-line HDF system that produces sterile fluids, enhancing treatment safety and effectiveness through intelligent monitoring and automation capabilities.

Furthermore, the SWS-5000, another award-winning innovation from the company, is recognized as a leading CRRT platform in China for three consecutive years. This comprehensive platform is designed to support integrated multi-organ blood purification therapies across renal, hepatic, cardiac, pulmonary, and pancreatic applications.

SWS Medical’s product lineup also includes advanced dialyzers produced using patented pressure steam sterilization with pre-vacuum technology and 100% BPA-free materials, ensuring high solute clearance and reliable ultrafiltration performance. In addition, the company offers dialysis liquid filters and hemoperfusion cartridges to enhance blood purification therapies.

Aligning with its vision for connected care, SWS Medical has developed an Integrated Management Platform that links dialysis centers, physicians, and patients via a centralized Data Center, Patient Card, and Hemodialysis Management System. This technology is set to transform data into safer, smarter patient care.

As a publicly traded medical device company, listed on the STAR Market (SSE 688410), SWS Medical plays a pivotal role in advancing China’s blood purification industry. The firm presides over the Strategic Alliance for Technological Innovation in China's Blood Purification Industry, contributing to national and industrial standard developments. With products certified for international standards, including CE marking and ISO 13485:2016 compliance, SWS Medical is dedicated to elevating healthcare globally.

For those interested in exploring SWS Medical's innovations firsthand, the company will be on-site at booth D-350 during ERA 2026. This event promises to be a significant opportunity for medical professionals to engage with leading-edge technology and innovations in the field of nephrology and beyond.

For more information, visit swsdialysis.com.

Contact for Media Inquiries: Marie Bédard, [email protected]